327 event(s) found
AONN+ 16th Annual Navigation & Survivorship Conference
The 4-day hybrid event is packed with opportunities to connect with peers, meet members of the AONN+ Leadership Council and/or Committee Chairs, share best practices, and get a glimpse of the latest innovations from exhibitors to aid in providing optimal patient care. Attendees will have the opportunity to earn continuing education contact hours over the conference’s 4-day span. Our agenda includes informative sessions on disease state discussions and practical solutions to daily navigation challenges, and accredited content.
Les Journées du FILO 2025
In French: "Le Groupe organise tous les ans des journées scientifiques pendant lesquelles sont discutés les aspects biologiques et cliniques des pathologies qui fédèrent ses membres ainsi que des sujets plus transversaux, en sollicitant la contribution d’intervenants extérieurs, français ou étrangers. Ces journées sont ouvertes et non restreintes aux seuls membres du FILO." Elles sont précédées d’une journée dédiée aux jeunes chercheurs ou cliniciens et au personnel de recherche clinique : - Journées JExL "Jeunes Experts de la Leucémie" avec présentations de travaux biologiques ou cliniques dont les meilleurs sont récompensés. Consultez ici les appels à communication et à projet. - Rencontres de Recherche Clinique : journée dédiée au personnel de recherche clinique.
2026 Nanets Multidisciplinary NET Medical Symposium
Join us for a premier opportunity to expand your knowledge, connect with peers, and engage in meaningful conversations about the evolving landscape of NET diagnosis and treatment.
Frontiers in Cancer Science 2026
Multidisciplinary conference presenting cutting-edge research in cancer biology and therapeutic strategies.
47èmes Journées de la SFSPM : Comment intégrer l’intelligence artificielle dans la prise en charge des cancers du sein : défis et perspectives
in French: "Les Journées de la SFSPM représentent un rendez-vous incontournable pour les professionnels de santé et les chercheurs impliqués dans la prévention, le diagnostic, et le traitement des pathologies mammaires. Organisé chaque année, cet événement scientifique et médical réunit des experts de diverses disciplines de la sénologie."
COSA Annual Scientific Meeting 2026
COSA Annual Scientific Meeting 2026 organized by Clinical Oncology Society of Australia (COSA)
Hematocon 2026: 67th Annual Conference of ISHBT
The Premier Hematology Conference in India! The theme of this year's edition is “Advancing Hematology: From Evidence to Clinical Excellence”. This event promises a rich academic experience, featuring a carefully curated program of lectures by distinguished national and international faculty, interactive workshops, and a host of engaging sessions. We have designed the event to offer both intellectual stimulation and meaningful networking opportunities. The conference will cover the latest advances in hematology, including benign hematology, malignant hematology, transfusion medicine, stem cell transplantation, molecular diagnostics, and laboratory hematology.
SNO Annual Meeting 2026: 31st Annual Meeting & Education Day of the Society for Neuro-Oncology
The SNO Annual Meeting is the world’s largest neuro-oncology conference, regularly attracting more than 3,000 researchers and clinician scientists from over 40 countries. Spanning all neuro-oncology disciplines, professions, and interests, #SNO2026 will serve as the premier forum to share knowledge and gain insights into the future of neuro-oncology research and treatment. The theme of #SNO2026, Crossing the Translational Divide: From Neurons to Novel Therapies. While the full scientific program is still in development, we are excited to announce that two distinguished keynote speakers have already been confirmed, with additional details to be shared in the coming months.
Online Event: ICPO Virtual Theranostics Summit 2026
Virtual conference with international experts from academia and industry in the field of theranostics in precision oncology. After a very successful 2nd edition in 2024 with over 400 participants, the ICPO Foundation is delighted to announce its next ICPO Theranostics Virtual Summit in 2026 – a must-attend online event gathering hundreds of international healthcare professionals passionate about Theranostics! The virtual event will feature renowned international experts from the ICPO Community who will present on the latest innovations, clinical insights, and patient-centered advances in Theranostics, and with whom you will be able to interact online. The ICPO Summit will be uniquely chaired by a trio of exceptions, namely: Prof. Richard P. Baum, Trustee of ICPO Foundation, President of ICPO Academy for Theranostics and Theranostics Lead Physician at Curanosticum, Wiesbaden-Frankfurt, Germany, Prof. Frederik L. Giesel, Head of Nuclear Medicine at University Clinic Düsseldorf, Germany Prof. Rudolf A. Werner, Head of Nuclear Medicine at University Clinic LMU, Munich, Germany.
AAGL26: 55th Global Conference on MIGS
This year's meeting features an innovative program focused on minimally invasive gynecologic surgery with emphasis on cutting-edge technology and breakthrough research. The theme is "Empowering Women's Voices: Surgical Excellence, Digital Transformation & Outcomes-Driven Care - Advancing Awareness, Access & Autonomy Worldwide"
2026 ESMO AI and Digital Oncology Congress
The ESMO AI & Digital Oncology Congress is a central meeting point for the latest research, ethical dialogue, and technological innovation in cancer care. Bringing together healthcare and digital health experts from around the world, it fosters collaboration, inspires learning and empowers oncology professionals to stay ahead in the digital transformation of medicine.
The Robert A. Winn Excellence In Clinical Trials Award Program: Design and Implementation of Clinical Trials Workshop
The Robert A. Winn Excellence in Clinical Trials: Career Development Award (Winn CDA), supported by the Bristol Myers Squibb Foundation, is a 2-year program designed to support the career development of early-stage investigator physicians who have a demonstrated commitment to transforming and expanding access to the clinical research landscape. They will become community-oriented clinical trialists who will drive improved health outcomes through their research and mentoring. Currently, our clinical research areas include cancer, cardiovascular disease and immunologic disorders. The Winn CDA offers a comprehensive and integrated approach to improving participation in clinical trials through workforce development and mentoring. The program kicks off with a virtual orientation in October and an in-person 4.5-5-day intensive workshop titled the Robert A. Winn Excellence in Clinical Trials: Design and Implementation of Clinical Trials in partnership with the American Association for Cancer Research® (Winn-AACR DICT Workshop) from November 17-21, 2025, in Albuquerque, NM. The workshop imparts essential knowledge about clinical trials design, development, implementation, and community engagement.
LEUKEMIA 360 - 3rd Edition
The premier international meeting devoted to academia-industry leukemia R&D&I partnering. An event organized by OPALE, The Organization for Partnerships in Leukemia.
Protein Sciences in Drug Discovery 2026
More information coming soon…
CNRC 2026 (16ème Congrès National des Réseaux de Cancérologie)
In French : "Le Congrès National des Réseaux de Cancérologie (CNRC) est un événement annuel majeur dans le domaine de la cancérologie, réunissant plus de 500 experts nationaux & régionaux, acteurs de la coordination des parcours de soins, professionnels de santé, associations de patients et représentants de l’industrie. Il permet de partager des connaissances, d’échanger sur les dernières avancées en matière de coordination, et de favoriser la collaboration entre les différents acteurs impliqués dans la prise en charge de patients atteints de cancer."
Prix 2026 du Cancéropôle IDF
In French: "Le Cancéropôle Île-de-France lance l’appel à candidature pour les Prix du Cancéropôle Île-de-France 2026 destinés à récompenser 3 doctorants ou post-doctorants franciliens dans le domaine du cancer. Le Prix du Cancéropôle Île-de-France est destiné à valoriser et à récompenser les travaux de doctorants ou post-doctorants travaillant en cancérologie dans des laboratoires de recherche académiques, exclusivement localisés en Région Île-de-France. Les doctorants ou post-doctorants franciliens de toutes disciplines (recherche fondamentale, clinique, translationnelle, shs, santé publique, …) travaillant dans le domaine du cancer sont éligibles. Les lauréats seront invités à présenter leurs travaux oralement en 5 minutes à l’occasion du 19e Colloque du Cancéropôle IDF qui se tiendra le 18 novembre 2026 à Paris. Les trois lauréats se verront attribuer un prix de 1500 € chacun. Date limite de participation : 3 juin 2026, midi. Annonce des résultats : septembre 2026"
MIN Symposium 2026
The MIN Spring Symposium is a 2-day meeting designed to bring together basic and clinical researchers to showcase immunotherapy-related research being conducted across Melbourne. The Symposium is a relaxed environment which encourages networking and collaboration with like-minded peers. Join us to hear from expert invited speakers, submit your research for the opportunity to contribute to the program as both an oral and/or poster presentation, and network at our conference dinner.
38th ENA (EORTC-NCI-AACR) Symposium on Molecular Targets and Cancer Therapeutics
Recognised as a leading forum for drug development and translational research, ENA 2026 will spotlight cutting-edge preclinical and phase I studies, fostering deep scientific exchange around emerging targets and novel therapeutics. Bringing together a global community of researchers, clinicians, and industry experts, the Symposium offers a dynamic platform to explore the latest breakthroughs in molecular biology, target identification, and drug innovation.
27th Annual Meeting of the Society of Urologic Oncology
More information coming soon...
AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer
Conference on liver cancer biology, immunotherapy, and translational research.
68th ASH Annual Meeting & Exposition
More information coming soon..
AACR Special Conference in Cancer Research: Cancer Biology-informed Radioligand Therapy
The goal of this conference is to convene experts in cancer biology, immunotherapy, and radioligand therapy (RLT) to discuss approaches to treating cancer with radioligand therapies and explore synergies with other treatments. With significant effort and interest in radioligand therapy by academia, industry, and government, paradigm-changing studies have demonstrated that combining molecular imaging and RLT has the possibility to dramatically impact cancer treatment. However, the major limitation for the further development of this field is a lack of fundamental knowledge of the mechanism(s) of action of systemic therapeutic isotopes with tumors, the tumor microenvironment, and the immune system. This conference is needed to engage experts from these diverse areas to not only educate on the state-of-the-art in radiotheranostics, but also to leverage the knowledge of cancer biologists, clinical oncologists, and immunologists to understand how RLT approaches work and how to overcome their limitations to drive the development of next generation therapies. Advancing RLT requires multi-disciplinary effort, with critical input from experts in radiochemistry, instrumentation, nuclear physics, and radiation biology. An unmet need in the field is advanced understanding of systemic radiobiology and cancer immunology as linked to therapeutic isotopes to fill gaps in knowledge across these domains. This AACR conference will focus on bringing together experts in these areas to discuss: 1) novel mechanisms of action of how systemic beta- and alpha-emitting isotopes interact with tumors, TME and the whole body to affect cures; 2) how RLT engages the immune system to mediate therapeutic efficacy; 3) rational approaches to treating cancer with novel isotopes and repurposed radioligand therapies; and 4) novel combinations and synergies with targeted and cellular therapies as well as external beam radiation, leveraging the strengths of each. Understanding how RLT interacts with the TME and the immune system are key to advancing novel therapies to treat an array of cancers.
AACR Lung Cancer Conference
Conference on advances in lung cancer biology, diagnosis, and treatment.
TTLC 2027
TTLC 2027 organized by IASLC